These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15593358)

  • 21. Medicaid re-enrollment policies and children's risk of hospitalizations for ambulatory care sensitive conditions.
    Bindman AB; Chattopadhyay A; Auerback GM
    Med Care; 2008 Oct; 46(10):1049-54. PubMed ID: 18815526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
    McCombs JS; Ahn J; Tencer T; Shi L
    J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of health care resources and cost of care for adults with constipation.
    Singh G; Lingala V; Wang H; Vadhavkar S; Kahler KH; Mithal A; Triadafilopoulos G
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1053-8. PubMed ID: 17625982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population.
    Chen H; Deshpande AD; Jiang R; Martin BC
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):629-38. PubMed ID: 15597329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome.
    Martin BC; Ganguly R; Pannicker S; Frech F; Barghout V
    Curr Med Res Opin; 2003; 19(8):771-80. PubMed ID: 14687449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of care for early- and late-stage oral and pharyngeal cancer in the California Medicaid population.
    Epstein JD; Knight TK; Epstein JB; Bride MA; Nichol MB
    Head Neck; 2008 Feb; 30(2):178-86. PubMed ID: 17694558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs of opioid abuse and misuse determined from a Medicaid database.
    McAdam-Marx C; Roland CL; Cleveland J; Oderda GM
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):5-18. PubMed ID: 20345194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.
    Gómez-Puerta JA; Barbhaiya M; Guan H; Feldman CH; Alarcón GS; Costenbader KH
    Arthritis Rheumatol; 2015 Mar; 67(3):752-60. PubMed ID: 25590668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How does Cash and Counseling affect costs?
    Dale SB; Brown RS
    Health Serv Res; 2007 Feb; 42(1 Pt 2):488-509. PubMed ID: 17244294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial/ethnic disparities in mental health treatment in six Medicaid programs.
    Samnaliev M; McGovern MP; Clark RE
    J Health Care Poor Underserved; 2009 Feb; 20(1):165-76. PubMed ID: 19202255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in outpatient mental health service utilization under capitation.
    Chou AF; Wallace N; Bloom JR; Hu TW
    J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost and utilization analysis of a pediatric emergency department diversion project.
    Wang C; Villar ME; Mulligan DA; Hansen T
    Pediatrics; 2005 Nov; 116(5):1075-9. PubMed ID: 16263992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort.
    Peschken CA; Katz SJ; Silverman E; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga HO; Gladman DD; Urowitz M; Zummer M; Clarke A; Bernatsky S; Hudson M;
    J Rheumatol; 2009 Jun; 36(6):1200-8. PubMed ID: 19369456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis.
    Bhosle MJ; Feldman SR; Camacho FT; Timothy Whitmire J; Nahata MC; Balkrishnan R
    J Dermatolog Treat; 2006; 17(5):294-301. PubMed ID: 17092860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.